NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Ma, Cynthia X CX; Gao, Feng F; Luo, Jingqin J; Northfelt, Donald W DW; Goetz, Matthew M; Forero, Andres A; Hoog, Jeremy J; Naughton, Michael M; Ademuyiwa, Foluso F; Suresh, Rama R; Anderson, Karen S KS; Margenthaler, Julie J; Aft, Rebecca R; Hobday, Timothy T; Moynihan, Timothy T; Gillanders, William W; Cyr, Amy A; Eberlein, Timothy J TJ; Hieken, Tina T; Krontiras, Helen H; Guo, Zhanfang Z; Lee, Michelle V MV; Spies, Nicholas C NC; Skidmore, Zachary L ZL; Griffith, Obi L OL; Griffith, Malachi M; Thomas, Shana S; Bumb, Caroline C; Vij, Kiran K; Bartlett, Cynthia Huang CH; Koehler, Maria M; Al-Kateb, Hussam H; Sanati, Souzan S; Ellis, Matthew J MJ